Parliament Workbench
Data: Official Report to 19 Nov 2026

Official Report · Committee

Continued Petitions

Prescribed Drug Dependence and Withdrawal (PE1651)

Thursday 18 January 2018 Public Petitions Committee About 10:15–11:15 Petitions 82 contributions · 7 speakers

Speakers

Choose an MSP to read only their contributions

The record

82 contributions
Johann Lamont Lab The Convener · Glasgow
link

Our second item is evidence on PE1651 by Marion Brown. We last considered the petition on 7 December 2017 and agreed that we would seek oral evidence from the Minister for Mental Health.

The minister and Dr Mitchell have remained with us for this item, and I welcome Jenny Simons, policy officer in the mental health and protection of rights division of the Scottish Government.

As members will know, we have received a large number of submissions on the petition, primarily from people who wish to let us know about their experiences of prescribed drug dependence and withdrawal. I extend our thanks to all those who have taken the time to provide their views.

Our role is not to look into the circumstances of any individual case, but the submissions that we have received convey the strength and depth of feeling that exists on this issue for a range of people. I am sure that I speak for everybody on the committee when I say that reading through the submissions in preparation for the committee had a significant impact. We are genuinely grateful because we know that people are not writing about something theoretical; they are writing about their own direct experience.

I invite the minister to make some opening remarks before we turn to questions from committee members.

Maureen Watt SNP Aberdeen South and North Kincardine
link

I start by thanking the petitioner, Marion Brown, who submitted the petition on behalf of Recovery and Renewal.

Prescribed drug dependence and withdrawal is an important issue, and that is, as the convener said, demonstrated by the level of response to the petition. I am grateful to those who have taken the time to share their personal experiences, many of which I have also read. Psychological therapies have an important role to play in helping people who have mental health problems, who should have access to effective physical and psychological treatment, and I welcome the opportunity to discuss the issue in more detail.

The Scottish Government will continue to emphasise the importance of parity in physical and mental health services. People who have a mental illness should expect the same standard of care as people who have a physical illness, and they should receive medication if they need it, just as someone should receive medication for a physical illness.

The Scottish Government has worked hard with partner organisations to reduce the stigma that is faced by people who have mental health problems, and that has been reflected in the rise in demand for mental health services across Scotland. As the stigma declines, we see more people coming forward to seek help from their GPs for problems such as depression. As a consequence, more people have been prescribed antidepressants, but that has been accompanied by better diagnosis and treatment of depression by GPs.

The responses to the petition highlight the issue of appropriate prescribing. As far as guidance on the prescribing of mental health drugs in Scotland is concerned, the SIGN guidelines provide evidence-based clinical practice guidelines for the NHS in Scotland. SIGN guidelines are designed to bring new knowledge into action to meet our aim of reducing variations in practice and improving outcomes. They are produced in collaboration with patients, carers and members of the public. SIGN guideline 114, which is on non-pharmaceutical therapies, encompasses psychological therapies, structured exercise and lifestyle interventions, and a range of alternative and complementary treatments in the management of depression.

Prescribing often involves not just drugs. Although we will ensure that people who need medication will continue to receive it, we are committed to improving access to psychological therapies that increase choice and best accommodate patient preference. As part of our 10-year strategy, we are taking a range of actions to transform mental health services in Scotland to respond to that need. Those actions include work to improve access to services, the development of new models of care within primary health services and a national roll-out of cognitive behavioural therapy, as well as the development of interventions for people in crisis through the distress brief intervention pilots that are being funded across Scotland.

Furthermore, although medical student teaching now emphasises that medication has an important place in treatment, it should not be overused or continued indefinitely, and decisions should always involve the patient so that they understand the potential benefits and risks of deciding to take medication. That process needs to take place within an enabling environment, in which support and a range of information sources are readily accessible to patients.

Our guiding ambition for mental health—that we must prevent and treat mental health problems with the same commitment, passion and drive with which we treat physical health problems—is simple but, if it is realised, it will change and save lives. We want to create a Scotland in which all stigma and discrimination related to mental health is challenged, and our collective understanding of how to prevent and treat mental health problems is increased. We want our nation to be one in which mental healthcare is person centred and recognises the life-changing benefits of fast and effective treatment.

I am happy to answer questions.

Johann Lamont Lab The Convener · Glasgow
link

Thank you very much, minister. A theme of the submissions that we received was people’s concern about being prescribed drugs without adequate explanation of the consequences of that and without having access to any other support, and then being left on them for a long time without being given support to come off them. That is the underlying concern that has been identified by the petitioners and others.

In the previous evidence session, we discussed the issue of GP training in relation to prescribing decisions, and I would like to ask a related question on PE1651 about the training that is available to GPs. The petitioner has commented that GPs are being held responsible by everyone, but that they do not have the expertise, knowledge or training to support people to safely come off such prescriptions. How would you respond to that?

Maureen Watt SNP Aberdeen South and North Kincardine
link

As I said in relation to PE1627, in 2014 the Scottish Government published key information on the use of antidepressants in Scotland, which illustrated that the quality of antidepressant prescribing appears to have improved in recent years. Too often, a less than effective dose was prescribed for too short a period of time. Now, higher average doses are prescribed for longer, more appropriate periods. That is a more effective approach, which reduces the risk of recurrent bouts of illness in the long term.

As the briefing paper highlights, the rise in the prescription of antidepressants in Scotland is explained, for the most part, by the better diagnosis and treatment of depression by GPs. Research that has been carried out in academic centres in Scotland confirms that antidepressants are being prescribed in line with the endorsed clinical guidelines and that such improvements will continue.

There is consistent evidence of undertreatment of depression and we know that the personal and economic costs of having it are high. We need to continue to work on ways to improve the recognition and effective treatment of depression.

The use of antidepressants by an individual is a dynamic process and varies due to the relapsing and remitting nature of the illness and individual treatment preferences. It does not work for everyone but, for those who respond to it, the evidence for antidepressant treatment reducing relapse is strong. There is no evidence that having greater access to psychological therapies will reduce antidepressant prescribing. Rather, access to appropriate and effective treatments, which will include antidepressants, is improved.

Johann Lamont Lab The Convener · Glasgow
link

I am concerned by that response because you seem to be saying that the problem is being addressed by giving people stronger drugs and leaving them on those drugs for longer. The petitioner says that people are being given drugs without the appropriate information about the consequences and being left on them without other supports, and that the GPs do not have the expertise to support them through the withdrawal of those drugs. That is the core of the petition. I asked you specifically what support GPs have been given on the matter. What expertise do they have to support people through the withdrawal of those drugs?

Maureen Watt SNP Aberdeen South and North Kincardine
link

That is a more clinical question, so John Mitchell will answer it.

Dr Mitchell
link

The drugs that we are talking about—the ones that can cause withdrawal problems—include the painkillers, particularly opiate medications, that may be prescribed not only by GPs but by specialists in hospitals in, for example, cancer care, and the sleeping tablet drugs such as benzodiazepines and the Z-drugs, which are antianxiety and sleep medicines and which may also be prescribed by GPs and specialists.

Those two classes of drugs cause dependence, in that the body of a patient who stays on the drug becomes tolerant of it and the dose has to be increased if it is to continue to have the same effect. When they stop taking the drug, they get withdrawal symptoms. That is the definition of dependence. Antidepressants have withdrawal side effects—they have discontinuation reactions—but they do not cause dependence in the same way as other drugs do. That is, tolerance is not associated with them—we do not have to keep pushing the dose up to get the same effect.

The point that you made first, convener, about the decision-making relationship between the patient and the prescriber is at the heart and soul of realistic medicine and the work that is going on through that. Not only is there the work on consent that we talked about in our previous evidence, but there is the health literacy action plan for Scotland, which is about how we have conversations with people about the treatments that we provide for them and which is being revised.

I will address the point that you made about GPs being on their own with the issue. It is not so much the GP as it is the prescriber who is responsible—the prescriber is responsible for the prescribing of all of those drugs, the potential side effects and the potential withdrawal problems. There is now a variety of different prescribers. Obviously, there are specialists in hospitals, who may be doctors or pharmacists. There are also prescribers in primary care. Indeed, advanced nurse practitioners prescribe for some conditions. Therefore, I do not think that we expect GPs to be left feeling that they are on their own in managing the complications of prescribing across that range. However, a GP who initiated a medication would certainly be responsible for that treatment.

Johann Lamont Lab The Convener · Glasgow
link

Will you and the minister clarify whether you accept the premise of the petition that there are people who were not given proper advice about the consequences of taking these prescriptions, with the result that the idea of informed consent is a challenge? They are put on those drugs, not given other supports and left on them. Do you also accept that the GP does not know how to support them through the withdrawal of the drugs? That is the petition’s fundamental premise. Do you accept that that has happened and continues to happen? Does it concern you that it happens?

Maureen Watt SNP Aberdeen South and North Kincardine
link

I would not accept the premise that it happens routinely. Obviously, the petitioner feels that it has happened in some cases.

Maureen Watt SNP Aberdeen South and North Kincardine
link

As I have said, the petitioner feels that it has happened.

10:45

Johann Lamont Lab The Convener · Glasgow
link

Do you think that it happens? It does not have to happen routinely for us to be concerned about it. Do GPs have the right support? If you do not accept that it happens, that is fine, but if you accept that it happens, what is the Government’s response in addressing the concerns highlighted by the petitioner? We cannot continue to prescribe stronger drugs for longer.

Dr Mitchell
link

I am happy to accept that as people’s description of their care.

Dr Mitchell
link

Yes.

Johann Lamont Lab The Convener · Glasgow
link

There is a difference between saying that somebody thinks that they feel something and saying that they feel something that is legitimate.

Dr Mitchell
link

Yes.

Johann Lamont Lab The Convener · Glasgow
link

So you accept that it is a legitimate concern.

Dr Mitchell
link

Yes. I recognise and accept the descriptions that people have given of the problems that they have had with prescribed medicine, although those descriptions do not represent the normal or average experience. They are situations that people have chosen to tell us about.

In respect of people’s feelings about the quality of the consent and information conversation that they had with the prescriber, I am happy to accept that there will be occasions when those conversations are not as good as they could be. However, other conversations, in which the prescriber explains what a person’s options are and discusses the pros and cons of those, might be extremely good.

GPs are in a primary care team and have access to guidance, as we discussed earlier. They can pick up the phone and speak to specialists if they want to. They have the opportunity to talk to other GPs—they describe doing that regularly—about clinical situations that they are involved with.

Specifically in relation to prescribing, we are rolling out improved pharmacy, both in the community and in primary care. Health boards tell us that by March 2018, we will have 200 new whole-time equivalent pharmacists in addition to 50 pharmacy assistants in practices across Scotland. GPs are not isolated in having to struggle with complicated prescribing issues—the support is there for them and they tell us that they are using it.

Maureen Watt SNP Aberdeen South and North Kincardine
link

Jenny Simons can add something about the matrix.

Jenny Simons Scottish Government
link

NHS Scotland has developed a psychological therapies matrix, which is an evidence-based resource that highlights different combinations of therapies and approaches to treating a range of different conditions. The guidance on depression forms a large part of that and is about how medications and different approaches to therapies and other sources of support can be combined, and doctors have that available to them. That is worth highlighting, as is the SIGN guidance, which has been developed in Scotland for GPs and other practitioners and clinical staff to refer to.

Rona Mackay SNP Strathkelvin and Bearsden
link

Do we have statistics on the number of people suffering withdrawal from antidepressants or prescription drugs?

Dr Mitchell
link

We do not have a unified number that describes that. The Royal College of Psychiatrists did some research into discontinuation reaction to antidepressants, which it published on its website. I can find those numbers for you.

I think that the experience of discontinuation reactions from antidepressants is quite common: they are pretty much effects of every antidepressant from every class. However, in general, the actual discontinuation reactions—the symptoms—are mild and self-limiting.

We cannot really define how severe or challenging the issue is, but—as I say—the Royal College of Psychiatrists has information from a survey and we are perfectly happy to accept that. These are real symptoms that people are having. Certainly for people who are on the dependent drugs such as opiates and benzodiazepines, without careful handling, almost 100 per cent of people would have withdrawal reactions. That is why there is clinical guidance and information available to help people work out how to cut down and reduce drug doses.

For antidepressants, the Royal College of Psychiatrists says that tapering should take place over four weeks in order to allow the body to adjust to those medicines.

Rona Mackay SNP Strathkelvin and Bearsden
link

Do you feel that the patient is being given enough information about the possible side effects, including the effects of withdrawal? Is it down to the GP to manage that?

Dr Mitchell
link

The prescribing of a medicine and then what happens with that medicine is the responsibility of the person who does the prescribing. The GMC is quite clear about the responsibilities of doctors in that respect.

Clearly, those who have given evidence have described feeling that they have not been listened to, involved or properly informed. However, in my clinical experience and from talking to other doctors, whether or not they are representatives of professional bodies, I know that we want the best for our patients. No clinician wants a patient to suffer, either because of a disease or because of a problem with the treatment for that disease.

Doctors will work hard to try to make sure that they are delivering information in a way that is understandable and of a tolerable amount so that people can come to a true decision about what they want.

Rona Mackay SNP Strathkelvin and Bearsden
link

Clearly, the people who have given us submissions were not aware of the possible side effects, including the effects of withdrawal, because I imagine that no one would agree to take a drug that would have such effects when they came off it. They just would not do it. Either they were not told or it was not explained clearly enough to them. Would you accept that?

Dr Mitchell
link

I do not know what happened in individual conversations. If you are put on any opiate painkiller, you would expect to be told that the painkiller is very strong and that when you stop it or come off it, that will need to be done carefully.

I think that people have a general understanding about painkillers and probably also about sleeping tablets—and certainly about antidepressants. It is the responsibility of the people prescribing to make sure that individuals are aware of potential side effects, including the withdrawal side effects.

Should a member of the public want to find out more about that, there is a leaflet about coming off antidepressants on the Royal College of Psychiatrists website, for example. There is also information on the NHS inform website that gives quite a lot of detail for people with medication problems about coming off medicines. People need to know that that information is there. That is good clinical practice, as described by the GMC, in terms of the relationship that the clinician has with their patient and how they are mutually following a course of action to the betterment of that patient’s situation.

Rona Mackay SNP Strathkelvin and Bearsden
link

Clearly, there is a problem. Presumably, only a small percentage of people experience severe, life-limiting side effects, but it happens, so the system is not perfect.

Dr Mitchell
link

No system is perfect—I accept that. The life-limiting consequences are rare. If a person had on-going major and severe difficulties as a consequence, support is available to help with that.

Rona Mackay SNP Strathkelvin and Bearsden
link

This is another case where statistics might be useful in order to get an idea of how many people suffer from severe symptoms.

Dr Mitchell
link

Again, it would be difficult to set a threshold for that. As I have said, we know that discontinuation reactions are common. The issue is deciding when the effects are self-limiting, which people will manage through good communication with the prescriber, and when there is an unusual situation in which more help is needed. It is difficult, because where would you draw the line across that spectrum of experience?

Rona Mackay SNP Strathkelvin and Bearsden
link

Minister, when you talked about the 10-year mental health strategy, you mentioned the new models of care in it. Will you expand on that aspect of the strategy?

Maureen Watt SNP Aberdeen South and North Kincardine
link

It is about making sure that people have a range of therapies available to them. As we discussed in relation to the previous petition, that might mean that people are not immediately put on antidepressants. Instead, following a discussion with their GP, they might be prescribed something from a range of therapies that includes psychological therapies, such as computerised cognitive behavioural therapy, or more exercise, given the correlation between exercise and depression.

I do not know whether you have spoken to the Scottish recovery network, but it has a range of treatments and interventions that are useful in helping people to recover from mental illness. That aspect of the strategy is about making sure that all the different combinations of treatments are available to the increased number of people who are presenting with mental illness.

Johann Lamont Lab The Convener · Glasgow
link

I give my usual early warning that, because of the rules of the Parliament, we must close the meeting by 20 to 12. I want the questioning to finish by half past 11. I ask members to focus so that we can cover all the areas within that time—although I should say that I am the only member who has strayed from our line of questioning so far.

Michelle Ballantyne Con South Scotland
link

How does the strategy relate to the delivery of the national performance framework and the mental wellbeing indicators? What we have heard so far has sent me into a bit of mental confusion. You stated that the 2014 review showed that the quality of prescribing has improved, that we are moving to longer, higher doses and that there is consistent evidence of undertreatment. However, you then said that the use of antidepressants is a dynamic process and that there is no evidence that greater access to psychological therapies reduces pharmacological prescribing, although you have just been talking about the importance of having alternative treatments available. Where is the strategy going? What are you trying to achieve? There seems to be a contradiction in the statements that you have made.

Maureen Watt SNP Aberdeen South and North Kincardine
link

As we discussed earlier, the short-life working group that Dr Mitchell chaired came to the conclusion that, in the treatment of depression in certain mental illness conditions, it is better to prescribe a higher dosage for longer, and the same conclusion has appeared in various articles and journals. I am not the clinician here. Furthermore, we know that medical prescribing, when used in combination with other therapies, may result in a better outcome. Therefore, the Scottish Government must ensure that those alternatives are available.

Michelle Ballantyne Con South Scotland
link

If I understand you correctly, you are suggesting that non-pharmacological options should be combined with prescribing and that you do not see the strategy moving us towards reducing prescribing.

11:00

Maureen Watt SNP Aberdeen South and North Kincardine
link

It is not for a strategy to do that. That is a decision for clinicians, given their knowledge.

Dr Mitchell
link

It was not me but my predecessor who chaired the expert group. We are saying that we want people to get the treatment that they need for their condition. As I explained earlier, my predecessor set up the expert group and wrote the published report because of concern about the rising number of prescriptions and because we were in the changeover from HEAT targets for the prescribing of antidepressants to targets for psychological therapy delivery.

At the time, there was a question about whether the increase in the use of psychological therapies meant that there would be a reduction in antidepressant use. The available evidence, which the group found from a variety of sources that were cited in the paper, did not support that. It implied that, in the better treatment of a condition such as depression, there should be more people taking medication, because medication works for some types of depression; there should be more psychological therapy, because there is a strong evidence base for cognitive behavioural therapy treating depression well; and there should be more social therapies and social support, because we know that they improve the condition. All those things go hand in hand towards improving access and treatment. Getting one thing does not mean that someone gets less of another; in fact, they get an uplift in all of them.

Generally, when adults present with depression, before a GP reaches for a prescription pad they think about the social, occupational and family environments of the person and about what the person could do through sport or through reducing their alcohol consumption—if alcohol is problematic—to improve their mood. They start by asking, “Might you want to talk to somebody about this?” and saying, “We have these resources available for you” before they tell the person, “I think you need to go on an antidepressant.” The only situation in which that would be trumped is in specialist care. For example, if I had a referral from a GP of somebody with depression who was not eating or drinking and who was actively suicidal and psychotic, I would say that that person needed to be on medicine. In some situations, medicines are life saving.

Michelle Ballantyne Con South Scotland
link

What does the mental health strategy say about the physical wellbeing of people with mental health disorders who are put on antidepressants? Was any consideration given to the link to people’s physical wellbeing?

Maureen Watt SNP Aberdeen South and North Kincardine
link

Absolutely. One of the key threads throughout the whole mental health strategy is that doctors and others should look at the whole person. They should look, for example, at whether a mental health condition is the result of a physical condition that is not being treated and at whether a physical condition is the result of someone having a mental health condition. We know that people with mental health conditions are likely to have their longevity reduced by 15 to 20 years, which is a health inequality that we must address. That is one reason for the thread that runs through the mental health strategy about doctors and others having the time and space to look at the person as a whole. It is hoped that the new GP contract will give them that time and space.

Michelle Ballantyne Con South Scotland
link

We have heard it suggested that tests such as quantitative electroencephalographs or SPECT—single-photon emission computed tomography—scans of the brain can assist people who have been on antidepressants and have experienced problems with withdrawal. Can you tell the committee anything about that?

Dr Mitchell
link

I am not aware of any published evidence that brain scanning has any therapeutic effect on medication withdrawal.

Michelle Ballantyne Con South Scotland
link

Are there any options for managing withdrawal or recommendations about what should be done? If the recommendation is that people should be on those drugs for longer and should take higher doses, is there anything in the strategy about what needs to be done to bring people off them?

Maureen Watt SNP Aberdeen South and North Kincardine
link

That information is not in the strategy, which is at a higher level than telling doctors how to do things. Jenny Simons mentioned the matrix, which was produced with NHS Education Scotland as a stepped guide to planning and delivering evidence-based psychological treatment. It has sections on depression and attention deficit hyperactivity disorder. For each medicine, there is a leaflet that tells us how to use it, the recommended dosage and what to expect. A lot of people might not read the leaflets, but they are available. I have had cause to read some with regard to antidepressants. NES has produced a booklet for the general public that is titled “Psychological Therapies in Scotland: Information for Service Users and Carers”, and the matrix sets out those therapies.

A GP will hold review consultations at stages with a patient who is on antidepressants, and any decision to take a person off them will be taken by the patient in conjunction with the prescriber.

Angus MacDonald SNP Falkirk East
link

The British Medical Association has recognised that there is an issue with prescribed drug dependency and has called for policy changes that include a national 24-hour helpline. The Scottish Government stated in its written submission that, although such a helpline has merit, the resources to help people who have addictions have already been allocated. What engagement has the Scottish Government had with the BMA on the establishment of a helpline? What services are in place to help people who are addicted to prescribed medication?

Maureen Watt SNP Aberdeen South and North Kincardine
link

We are aware of the BMA’s call for a helpline. However, in discussing the petition, we would indicate strongly that the best person to help with withdrawal from antidepressants is the person who prescribed them in the first place. They will know the clinical history of the person who has been on the drugs.

That said, if people want to seek other advice, NHS 24 and NHS inform operate in Scotland, and community pharmacists are in a position to give advice. Problematic withdrawal is best managed by the day-to-day services rather than through a helpline whose operator does not know the history of the caller—that is our strong recommendation. John Mitchell has been in touch with NHS 24 about that specific issue.

Dr Mitchell
link

We have seen the BMA’s evidence to the committee, and we are aware of the work of the all-party parliamentary group for prescribed drug dependence at Westminster, to which the BMA has written a detailed letter in response to the Department of Health’s proposal that telephonic support should be provided through its 111 NHS telephone service. We have read with interest the BMA’s comments about the English 111 service and the English NHS choices website and information service.

We have discussed the BMA’s comments with the Department of Health in Scotland and have asked NHS 24 in Scotland what our response would be if a person who was struggling to come off medication of any sort phoned NHS 24 for help. NHS 24 has said that it receives such calls and points out that it has a nursing telephonic service and material on the NHS inform website as well as pharmacy advisers to provide a higher level of advice. However, it has also said that, beyond the call being made, it would advise a Scot who phones up to discuss the matter first and foremost with the original prescriber of the medicine, as the minister has said, and, if need be, to seek advice from a community pharmacy or the pharmacy supporting the primary care team or centre.

Angus MacDonald SNP Falkirk East
link

Have you had any discussions with the BMA to that effect?

Dr Mitchell
link

We have not spoken directly to the BMA. I tried to contact the Scottish secretary this week, but he is on annual leave.

Dr Mitchell
link

Yes.

Maureen Watt SNP Aberdeen South and North Kincardine
link

The Royal College of Psychiatrists has recognised the issue, and a leaflet that it has issued on coming off antidepressants is available on its website.

Angus MacDonald SNP Falkirk East
link

The Scottish Government’s written submission refers to alternatives to medication being referenced in SIGN guidelines. However, the petitioner has stated:

“Waiting times for availability of non-pharmacological treatment make a mockery of the application of this existing SIGN guidance.”

How do you respond to that concern?

Maureen Watt SNP Aberdeen South and North Kincardine
link

We have recognised that problem in the mental health strategy. Just a couple of months ago, I gave NHS 24 an extra £500,000 to develop its online services, which include computerised cognitive behavioural therapy. We are aware that some—though not all—people prefer to use online services, and we are trying to ensure that they are more widely known about and available. Moreover, NHS 24 has an on-going telephone counselling service as part of its overall service, which many people have found extremely helpful. There will be a further expansion of online services, and there are funding packages in the mental health strategy for developing and enhancing the supply and training of the workforce for evidence-based therapies.

Angus MacDonald SNP Falkirk East
link

An issue that has come up in a number of submissions is the off-label prescribing of medication, which I take to mean the prescribing of medication for the treatment of symptoms or conditions outside the terms of the licence for that medication. I am curious about whether you recognise that issue and, if you do, whether the Scottish Government can take any action on it.

Maureen Watt SNP Aberdeen South and North Kincardine
link

I think that that is a clinical question for John Mitchell.

Dr Mitchell
link

In the United Kingdom, the licensing of medication is carried out by the Medicines and Healthcare products Regulatory Agency, and its decisions translate into the information in the British national formulary, which is the UK-wide go-to book for prescribers. It says that a certain drug should be used for certain conditions and not for others, and it provides information in that respect.

The best practice for clinicians is to follow the British national formulary and licensing arrangements. However, research on the circumstances in which a certain medicine might work is sometimes behind the curve, because medication trials require huge numbers of people and, in order to be valid, need to compare the drug in question with a placebo or the usual treatment. There are clinical situations in which it is simply not possible, because of a lack of numbers or other issues, to do the research.

11:15

A good example of that is antidepressant use in children. Because antidepressants are prescribed to children so seldom, and because we use 20-odd antidepressants, if we conducted a randomised controlled trial in which we randomly compared the use of a particular medication to treat a child with depression with the use of a placebo or a different treatment, we would not have sufficient numbers to enable us to know whether we had got a true finding. There would also be huge consent and ethical issues in our doing that.

As medications become more widely used, academic centres and experts might well try out medicines in situations in which they are not licensed to be used, because there is no evidence base to show that they work in treating a particular condition, but in which experts and academics have found anecdotal evidence that they work. Specialists often manage complex situations, and they apply their expertise in determining how best to help their patients. They would, of course, seek to use medications that were first-line British national formulary products. However, if those medicines did not work, there might be situations in which they would say to the person concerned, “This medicine is not licensed for treating your condition, but there is evidence that it might help. Do you want to try it?” It would be best practice for that conversation to be open and transparent. Any prescriber who wants to use a medicine for an off-licence indication should make very clear to the person concerned what they are doing and should record the fact that they are doing it—including why they are doing it—in the case notes. Such situations are unusual, but they are far from rare.

Angus MacDonald SNP Falkirk East
link

Thank you for that interesting response. Perhaps we can look at how it relates to another petition that we are considering, which is on thyroid hormone replacement treatment, at some point in the future.

Rona Mackay SNP Strathkelvin and Bearsden
link

My question relates to an issue that Dr Mitchell touched on in answer to Michelle Ballantyne. The petitioner has commented on what she calls the catch-22 situation that doctors face, whereby they sometimes feel under pressure to prescribe drugs when someone is contemplating suicide, on the basis that non-pharmacological treatments cannot be immediately accessed and because there is a perception that prescribing medication is more defensible than not doing so. In other words, GPs take a safe route in the treatment of such patients.

Could you expand on your concerns about that comment?

Dr Mitchell
link

I do not think that I recognise that description. If a doctor had a patient whom they felt was actively suicidal, they would seek emergency specialist help for them. They would not think, “I’ll give them an antidepressant and put them out the door.”

Rona Mackay SNP Strathkelvin and Bearsden
link

I am sorry. I thought that, in response to Michelle Ballantyne, you said that, in extremely serious cases, you would prescribe.

Dr Mitchell
link

As a consultant psychiatrist, I would do that in a situation in which somebody was an in-patient in a psychiatric hospital. A person’s safety trumps everything. In a situation in which a patient was not eating or drinking and whose life was at immediate risk, I would prescribe a medication for them, but I would admit them as an in-patient and would give them that medicine in a controlled and safe place.

Rona Mackay SNP Strathkelvin and Bearsden
link

If you were a GP and a patient came to you saying that they could not take any more and were feeling suicidal, are you saying that you would not prescribe, but would signpost them elsewhere?

Dr Mitchell
link

I am not a GP, but my experience is that a GP would contact the local community mental health team and say that this person needed to be seen now. The community mental health team would respond to that.

Rona Mackay SNP Strathkelvin and Bearsden
link

Are you confident that the response would be quick enough and that there would be no delay?

Dr Mitchell
link

That is the nature of community mental health teams. They do a lot of routine, scheduled work, but they also do a great deal of work that is considered to be urgent or emergency. Community mental health teams work on the basis that an emergency referral means that they must drop everything and deal with that immediately, and an urgent referral means that someone must be seen within 24 hours. More often than not, the referral form from the GP will be explicit about the level of intervention that they are seeking.

In a situation in which a GP is with a patient who is saying that they are actively suicidal, no community mental health team would be waiting for a typed up referral letter, but would deal with the practicalities of the situation there and then. It would be nice to get some information, but one would deal with the risk in the moment.

Rona Mackay SNP Strathkelvin and Bearsden
link

To summarise, you do not believe that GPs are generally using prescribing as a safe option or that they are prescribing just in case things get out of hand.

Dr Mitchell
link

No. I do not recognise that behaviour. A GP might argue the reverse. If a GP has someone in who gives them concern about their level of suicidality and they ask that person whether they were thinking of ending their life, but the person says, “No, I’m not,” the GP would wonder whether they could trust what the patient was saying. That is a common situation. The GP’s gut feeling might be that the patient was high risk, even though they were saying, “No, doctor, I’m not suicidal and I am not thinking of ending my life.” The GP’s concern might be that if they decided that that person was not actively suicidal and they gave them an antidepressant and sent them away, it might lead to greater criticism than not prescribing an antidepressant.

Maureen Watt SNP Aberdeen South and North Kincardine
link

I want to mention two things. First, we are running distress brief intervention pilots in six areas across Scotland, which give access within 24 hours to counsellors for anyone who presents to accident and emergency or who becomes known to the police or is in police custody. The pilots started in October—I went to visit the Lanarkshire pilot—and have already had some good feedback.

Secondly, the commitment to an extra 800 mental health workers is to address those issues, so that we can ensure that if someone presents out of hours they can get immediate help.

Johann Lamont Lab The Convener · Glasgow
link

I have one final point. You mentioned earlier that many drugs come with a little leaflet. Do you accept that a little leaflet has no authority in comparison with the authority of the GP? Should the GP humanise what the little leaflet says, so that people know what the consequences are?

Maureen Watt SNP Aberdeen South and North Kincardine
link

Yes. We all know that when we go to the GP, if the doctor prescribes something, they tell you what to expect from the prescription. However, I accept that there may be cases where that is not happening.

Michelle Ballantyne Con South Scotland
link

Could you comment on whether you accept the following statements that were given to us in evidence? The first statement is:

“Ten per cent of the population of Scotland takes an antidepressant on prescription. Of those between 80 and 90% are on treatment for more than a year - many for over a decade.”

Is that because it is good treatment, or because people are dependent?

The second statement is:

“At present rates of antidepressant use among adolescents in Scotland, especially among women, is rocketing. These drugs are or are on their way to being the most commonly used prescription drugs by Scottish adolescents.”

Do you recognise and agree with those statements?

Dr Mitchell
link

I do not recognise much of that. Antidepressants are certainly a commonly used medication. The guidance for treating depression says that if someone who is experiencing their first depression goes on antidepressants and the medication works for them, they should stay on it for six months before they come off it. If they have a recurrence of the depression, they should stay on the medication for two years. That guidance is internationally accepted and based on evidence.

For effective treatment of people with depression, if people respond to the drugs, they should be on them for that sort of timescale. They are not effective if they are used only for a month or for two months.

I grant that the study that was done on the prescribing of antidepressants is now six years old, but it indicated that the longer and more appropriate periods of time were being applied by GPs. It was new prescriptions of antidepressants and what happened to them that were being examined.

Johann Lamont Lab The Convener · Glasgow
link

I thank the minister and her officials for their evidence. I appreciate that you have done a double shift today, but it has been really useful.

I emphasise to anyone watching that we recognise the importance of mental health and that progress has been made, but the petitioner is presenting the challenge that there are issues that we need to address.

I am grateful for the witnesses’ attendance today. I am happy for you to remain for the final few minutes while we have a conversation about how we take the petition forward, but I am happy for you to leave if you have other commitments.

The committee needs to think again about the petition. I assume that we do not want to close it, and I am interested to hear members’ views.

Angus MacDonald SNP Falkirk East
link

We need to reflect on the evidence that we have heard today. Given what we heard from Dr Mitchell, I would be keen to hear what the BMA’s current position is with regard to the helpline. Dr Mitchell explained that NHS 24 discussions have highlighted that there is a service but I am still keen to get a response from the BMA.

Johann Lamont Lab The Convener · Glasgow
link

Perhaps the most effective thing to do would be to ask the clerks to reflect on the evidence and where we have highlighted that we want more information. Even in those final points that Michelle Ballantyne made, there is quite a lot around the prevalence of antidepressants and the length of time that people are on them. If the petitioner’s contention is that people are put on antidepressants but not supported, we want to explore that further.

Again, we also hope that the petitioner will reflect on the evidence and that she will, if she so chooses, provide us with more evidence.

Rona Mackay SNP Strathkelvin and Bearsden
link

The important thing is to get the petitioner’s response and to pick out the individual issues that have come up during evidence, such as statistics and so on, that we have asked for. That would be useful.

Michelle Ballantyne Con South Scotland
link

We need to hear from GPs about their experience of what we hear from both sides about a gulf in the evidence. We need to reflect on how we can do that.

Johann Lamont Lab The Convener · Glasgow
link

We also need to find out the extent to which there is a pressure. We have spoken about this in another context altogether. Defensive practice is where people feel that, for the want of a guarantee, they will do something else, and that is perfectly understandable. We might want to take that forward but, underneath all this, we recognise the challenges that health practitioners face in terms of pressure and managing their time.

Michelle Ballantyne Con South Scotland
link

There is also the disconnect that many GPs feel now in that when they are seeing a patient, trying to look at them holistically is now much more difficult than it was because they used to know their patients within the context of the society in which they lived and worked. Now, they only see them as a patient for 10 minutes. They do not know the family or other circumstances or how they live. The process has become much more complicated.

Johann Lamont Lab The Convener · Glasgow
link

Those are all useful comments, so I will ask the clerks to bring all this together. Any further responses from the petitioner will be welcome in informing our further action.

Once again, I thank the minister and her officials. I very much appreciate their input. I also thank all those who responded to the petition.

Meeting closed at 11:30.

  1. 09:00 Continued Petitions Petitions · 133
  2. 10:15 Continued Petitions Petitions · 82

The type of each item (debate, statement, questions, members’ business and so on) and the times shown are worked out by this site from headings, the chair’s opening words and the Official Report’s running timestamps. They are not the Parliament’s own classification. Text: the Scottish Parliament Official Report.